Brooke Hurford

Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA.

Minaris Regenerative Medicine LLC provides cell therapy services. It provides contract development and manufacturing organization (CDMO) services at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development. The company was founded by Robert A. Preti and Andrew L. Pecora in 1997 and is headquartered in Allendale, NJ.

Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.

International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

TrichoScience Innovations, Inc. provides hair cell replication services. The company was founded by Kevin McElwee, Jerry Shapiro, Rolf Hoffmann and Matthew J. Wayrynen and is headquartered in Vancouver, Canada.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada.

Gemstone Biotherapeutics LLC develops therapeutics and devices for wound care. It develops a range of tissue engineering inventions with particular emphasis on vascularization and angiogenesis for health care research and clinical markets. The company was founded in October 2013 and is headquartered in Baltimore, MD.

Cell Therapy Group (CTG) is a business-focused service provider in the cell-based regenerative medicine sector. The private company is based in Langley, Canada, and is quickly broadening its experience with cell therapy into the fast-emerging arena of cultured meat. CTG offers services to device, service, tools, and reagent companies, bio-therapeutic companies, investors, non-profit organizations, and consultants. The Canadian company excels in business development, strategy development, mergers & acquisitions, financings, turnaround & restructuring, operational buildout, market analysis, 3rd party contract service analysis, selection, and oversight, project management, and related consulting. CTG focuses on companies in the cell therapy sector in transition due to growth, distress, or disruption. The growing interface between the cultured meat and cell therapy industries is of particular interest to this group. The company was founded by Robert Lee Buckler in 2008 and has over 20 years of experience working with startups and top-10 pharma companies.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

Cell Therapy News provides free weekly updates of regenerative medicine, highlighting the top cell therapy, gene therapy and immunotherapy findings. The company was founded by Robert Lee Buckler in 2002 and is headquartered in Vancouver, Canada.

Redactbio, Inc. engages in gene editing and tissue engineering. The company is headquartered in Lexington, MA.

Part of STEMCELL Technologies Canada, Inc., Malachite Management, Inc. provides management services.